[HTML][HTML] The Value of TruScreen (An Artificial Intelligence Cervical Cancer Screening System) in High-Risk HPV Positive Patients
L Luo, J Zhang - Clinical and Experimental Obstetrics & Gynecology, 2023 - imrpress.com
Background: To investigate the value of the artificial intelligence cervical cancer screening
system TruScreen (TS) in high-risk human papillomavirus (HPV)-positive patients in a …
system TruScreen (TS) in high-risk human papillomavirus (HPV)-positive patients in a …
[PDF][PDF] A Performance Evaluation of an Optoelectronic Cervical Screening Device in Comparison to Cytology and HPV DNA Testing.
JN Vet, JP Haindl, C Velasquez, LJ Parker… - European Journal of …, 2022 - academia.edu
Objective: An optoelectronic screening device (OESD) is evaluated for the detection of
cervical intra-epithelial neoplasia (CIN) 2+ lesions in comparison to Liquid Based Cytology …
cervical intra-epithelial neoplasia (CIN) 2+ lesions in comparison to Liquid Based Cytology …
[HTML][HTML] ВОЗМОЖНОСТИ ОПТИКО-ЭЛЕКТРОННОЙ ДИАГНОСТИКИ ЦЕРВИКАЛЬНЫХ ПОРАЖЕНИЙ В СОВРЕМЕННЫХ УСЛОВИЯХ НА АППАРАТЕ …
НВ Зароченцева, ЛК Джиджихия… - Вопросы …, 2022 - cyberleninka.ru
В обзоре литературы представлен зарубежный и отечественный опыт оптико-
электронной диагностики цервикальных поражений на аппарате TruScreen …
электронной диагностики цервикальных поражений на аппарате TruScreen …